| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-101 |
Sentence |
denotes |
Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues. |
| T1 |
0-101 |
Sentence |
denotes |
Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues. |
| T1 |
0-101 |
Sentence |
denotes |
Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues. |
| TextSentencer_T2 |
102-236 |
Sentence |
denotes |
Dermatan sulfate is a glycosaminoglycan that selectively inhibits the action of thrombin through interaction with heparin cofactor II. |
| T2 |
102-236 |
Sentence |
denotes |
Dermatan sulfate is a glycosaminoglycan that selectively inhibits the action of thrombin through interaction with heparin cofactor II. |
| T2 |
102-236 |
Sentence |
denotes |
Dermatan sulfate is a glycosaminoglycan that selectively inhibits the action of thrombin through interaction with heparin cofactor II. |
| TextSentencer_T3 |
237-358 |
Sentence |
denotes |
Unlike heparin it does not interact with other coagulation factors and is able to inhibit thrombin associated with clots. |
| T3 |
237-358 |
Sentence |
denotes |
Unlike heparin it does not interact with other coagulation factors and is able to inhibit thrombin associated with clots. |
| T3 |
237-358 |
Sentence |
denotes |
Unlike heparin it does not interact with other coagulation factors and is able to inhibit thrombin associated with clots. |
| TextSentencer_T4 |
359-449 |
Sentence |
denotes |
This property has made dermatan sulfate an attractive candidate as an antithrombotic drug. |
| T4 |
359-449 |
Sentence |
denotes |
This property has made dermatan sulfate an attractive candidate as an antithrombotic drug. |
| T4 |
359-449 |
Sentence |
denotes |
This property has made dermatan sulfate an attractive candidate as an antithrombotic drug. |
| TextSentencer_T5 |
450-660 |
Sentence |
denotes |
Previous studies have showed that dermatan sulfate derived from porcine/bovine intestinal mucosa/skin or marine invertebrates is capable of stimulating heparin cofactor II-mediated thrombin inhibition in vitro. |
| T5 |
450-660 |
Sentence |
denotes |
Previous studies have showed that dermatan sulfate derived from porcine/bovine intestinal mucosa/skin or marine invertebrates is capable of stimulating heparin cofactor II-mediated thrombin inhibition in vitro. |
| T5 |
450-660 |
Sentence |
denotes |
Previous studies have showed that dermatan sulfate derived from porcine/bovine intestinal mucosa/skin or marine invertebrates is capable of stimulating heparin cofactor II-mediated thrombin inhibition in vitro. |
| TextSentencer_T6 |
661-822 |
Sentence |
denotes |
This biological activity is reported for the first time in this study using dermatan sulfate derived from mammalian tissues other than intestinal mucosa or skin. |
| T6 |
661-822 |
Sentence |
denotes |
This biological activity is reported for the first time in this study using dermatan sulfate derived from mammalian tissues other than intestinal mucosa or skin. |
| T6 |
661-822 |
Sentence |
denotes |
This biological activity is reported for the first time in this study using dermatan sulfate derived from mammalian tissues other than intestinal mucosa or skin. |
| TextSentencer_T7 |
823-1082 |
Sentence |
denotes |
Ten different bovine tissues including the aorta, diaphragm, eyes, large and small intestine, esophagus, skin, tendon, tongue, and tongue skin were used to prepare dermatan sulfate-enriched fractions by anion exchange chromatography and acetone precipitation. |
| T7 |
823-1082 |
Sentence |
denotes |
Ten different bovine tissues including the aorta, diaphragm, eyes, large and small intestine, esophagus, skin, tendon, tongue, and tongue skin were used to prepare dermatan sulfate-enriched fractions by anion exchange chromatography and acetone precipitation. |
| T7 |
823-1082 |
Sentence |
denotes |
Ten different bovine tissues including the aorta, diaphragm, eyes, large and small intestine, esophagus, skin, tendon, tongue, and tongue skin were used to prepare dermatan sulfate-enriched fractions by anion exchange chromatography and acetone precipitation. |
| TextSentencer_T8 |
1083-1292 |
Sentence |
denotes |
Heparin cofactor II/dermatan sulfate-mediated thrombin inhibition measured in vitro revealed activity comparable to or higher than the commercial standard with 2-fold differences observed between some tissues. |
| T8 |
1083-1292 |
Sentence |
denotes |
Heparin cofactor II/dermatan sulfate-mediated thrombin inhibition measured in vitro revealed activity comparable to or higher than the commercial standard with 2-fold differences observed between some tissues. |
| T8 |
1083-1292 |
Sentence |
denotes |
Heparin cofactor II/dermatan sulfate-mediated thrombin inhibition measured in vitro revealed activity comparable to or higher than the commercial standard with 2-fold differences observed between some tissues. |
| TextSentencer_T9 |
1293-1702 |
Sentence |
denotes |
Analysis of the extracted dermatan sulfate using fluorophore-assisted carbohydrate electrophoresis revealed significant differences in the relative percentage of all the mono-sulfated disaccharides, in particular the predominant mammalian disaccharide uronic acid-->N-acetyl-D-galactosamine-4-O-sulfate, confirming previous reports regarding variations in sulfation in dermatan sulfate from different tissues. |
| T9 |
1293-1702 |
Sentence |
denotes |
Analysis of the extracted dermatan sulfate using fluorophore-assisted carbohydrate electrophoresis revealed significant differences in the relative percentage of all the mono-sulfated disaccharides, in particular the predominant mammalian disaccharide uronic acid-->N-acetyl-D-galactosamine-4-O-sulfate, confirming previous reports regarding variations in sulfation in dermatan sulfate from different tissues. |
| T9 |
1293-1702 |
Sentence |
denotes |
Analysis of the extracted dermatan sulfate using fluorophore-assisted carbohydrate electrophoresis revealed significant differences in the relative percentage of all the mono-sulfated disaccharides, in particular the predominant mammalian disaccharide uronic acid-->N-acetyl-D-galactosamine-4-O-sulfate, confirming previous reports regarding variations in sulfation in dermatan sulfate from different tissues. |
| TextSentencer_T10 |
1703-2002 |
Sentence |
denotes |
Overall, these findings demonstrate that dermatan sulfate extracted from a range of bovine tissues exhibits in vitro antithrombin activity equivalent to or higher than that observed for porcine intestinal mucosa, identifying additional sources of dermatan sulfate as potential antithrombotic agents. |
| T10 |
1703-2002 |
Sentence |
denotes |
Overall, these findings demonstrate that dermatan sulfate extracted from a range of bovine tissues exhibits in vitro antithrombin activity equivalent to or higher than that observed for porcine intestinal mucosa, identifying additional sources of dermatan sulfate as potential antithrombotic agents. |
| T10 |
1703-2002 |
Sentence |
denotes |
Overall, these findings demonstrate that dermatan sulfate extracted from a range of bovine tissues exhibits in vitro antithrombin activity equivalent to or higher than that observed for porcine intestinal mucosa, identifying additional sources of dermatan sulfate as potential antithrombotic agents. |